AAAAAA
Results: 1-25/68
Authors:
GEBBIA V
FALLICA G
BORSELLINO N
TESTA A
VARVARA F
MAUCERI G
Citation: V. Gebbia et al., TREATMENT OF ADVANCED HEAD NECK SQUAMOUS-CELL CARCINOMA IN ELDERLY PATIENTS WITH WEEKLY INTRAVENOUS BLEOMYCIN/, Annals of oncology, 9, 1998, pp. 102-102
Authors:
MANTOVANI G
GEBBIA V
AIROLDI M
BUMMA C
CONTU P
BIANCHI A
GHIANI M
DESSI D
MASSA E
CURRELI L
LAMPIS B
LAI P
MULAS C
TESTA A
PROTO E
CADEDDU G
TORE G
Citation: G. Mantovani et al., NEOADJUVANT CHEMO-(IMMUNO-)THERAPY OF ADVANCED SQUAMOUS-CELL HEAD ANDNECK-CARCINOMA - A MULTICENTER, PHASE-III, RANDOMIZED STUDY COMPARINGCISPLATIN PLUS 5-FLUOROURACIL [5-FU] WITH CISPLATIN PLUS 5-FU PLUS RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 47(3), 1998, pp. 149-156
Authors:
NAGLIERI E
GEBBIA V
DURINI E
LELLI G
ABBATE I
SELVAGGI FP
DITONNO P
COLUCCI G
Citation: E. Naglieri et al., STANDARD INTERLEUKIN-2 (IL-2) AND INTERFERON-ALPHA IMMUNOTHERAPY VERSUS AN IL-2 AND 4-EPIRUBICIN IMMUNO-CHEMOTHERAPEUTIC ASSOCIATION IN METASTATIC RENAL-CELL CARCINOMA, Anticancer research, 18(3B), 1998, pp. 2021-2026
Authors:
BAJETTA E
DIBARTOLOMEO M
CARNAGHI C
BUZZONI R
MARIANI L
GEBBIA V
COMELLA G
PINOTTI G
IANNIELLO G
SCHIEPPATI G
BOCHICCHIO AM
MAIORINO L
Citation: E. Bajetta et al., FEP REGIMEN (EPIDOXORUBICIN, ETOPOSIDE AND CISPLATIN) IN ADVANCED GASTRIC-CANCER, WITH OR WITHOUT LOW-DOSE GM-CSF - AN ITALIAN TRIAL IN MEDICAL ONCOLOGY (ITMO) STUDY, British Journal of Cancer, 77(7), 1998, pp. 1149-1154
Authors:
GIOTTA F
MANZIONE L
GEBBIA V
BILANCIA D
GEBBIA N
COLUCCI G
Citation: F. Giotta et al., TAXOL (T) AND MITOXANTRONE (M) AS FIRST LINE TREATMENT IN ADVANCED BREAST-CANCER (ABC) PATIENTS - A PHASE-II STUDY OF THE SOUTHERN ITALY ONCOLOGY GROUP (GOIM), European journal of cancer, 33, 1997, pp. 688-688
Authors:
GEBBIA V
TESTA A
CANNATA G
TIRRITO ML
BORSELLINO N
VALERIO MR
VARVARA F
GEBBIA N
Citation: V. Gebbia et al., TREATMENT OF RECURRENT AND OR METASTATIC ADENO-CARCINOMA OF THE ENDOMETRIUM WITH CISPLATINUM AND VINOREL-BINE - A PHASE-II STUDY/, European journal of cancer, 33, 1997, pp. 934-934
Authors:
MAIELLO E
GEBBIA V
GIULIANI F
TESTA A
BORSELLINO N
GALETTA D
GEBBIA N
COLUCCI G
Citation: E. Maiello et al., ELFE (ETOPOSIDE, FOLINIC ACID, 5-FLUOROURACIL, AND EPIRUBICIN) REGIMEN IN THE TREATMENT OF ADVANCED PANCREATIC-CANCER (APC), European journal of cancer, 33, 1997, pp. 1270-1270
Authors:
COLUCCI G
GIOTTA F
GEBBIA V
RICCARDI F
PEZZELLA G
DURINI E
CARUSO M
ROMITO S
GEBBIA N
Citation: G. Colucci et al., DOSE INTENSIFICATION OF MITOXANTRONE IN COMBINATION WITH LEVOFOLINIC ACID, FLUOROURACIL, CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN ADVANCED UNTREATED BREAST-CANCER PATIENTS - A MULTICENTRIC PHASE-II STUDY OF THE SOUTHERN ITALY ONCOLOGY GROUP, Anti-cancer drugs, 8(3), 1997, pp. 257-264
Authors:
GEBBIA V
BORSELLINO N
TESTA A
LATTERI MA
MILIA V
VALDESI M
GIOTTA F
GEBBIA N
COLUCCI G
Citation: V. Gebbia et al., CISPLATIN AND EPIRUBICIN PLUS ORAL LONIDAMINE AS FIRST-LINE TREATMENTFOR METASTATIC BREAST-CANCER - A PHASE-II STUDY OF THE SOUTHERN ITALYONCOLOGY GROUP (GOIM), Anti-cancer drugs, 8(10), 1997, pp. 943-948
Authors:
GEBBIA V
MANTOVANI G
FARRIS A
AGOSTARA B
DESOGUS A
CURRELI L
MOSCHELLA F
DIGREGORIO C
BAJETTA E
GEBBIA N
Citation: V. Gebbia et al., VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL AS INITIAL TREATMENT FOR PREVIOUSLY UNTREATED, UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A PHASE-II MULTICENTER STUDY, Cancer, 79(7), 1997, pp. 1394-1400
Authors:
COLUCCI G
GEBBIA V
GALETTA D
RICCARDI F
CARIELLO S
GEBBIA N
Citation: G. Colucci et al., CISPLATIN AND VINORELBINE FOLLOWED BY IFOSFAMIDE PLUS EPIRUBICIN VS THE OPPOSITE SEQUENCE IN ADVANCED UNRESECTABLE STAGE-III AND METASTATICSTAGE-IV NON-SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF THE SOUTHERN ITALY ONCOLOGY GROUP (GOIM), British Journal of Cancer, 76(11), 1997, pp. 1509-1517
Authors:
GEBBIA V
TESTA A
CANNATA G
TIRRITO ML
LONGO A
SCIUME C
VALDESI M
SALAMONE G
GEBBIA N
LEO P
Citation: V. Gebbia et al., 2ND LINE CHEMOTHERAPY FOR METASTATIC COLORECTAL-CARCINOMA - A PHASE-II STUDY WITH MITOMYCIN-C, ADRIAMYCIN AND LONIDAMINE, Oncology Reports, 3(5), 1996, pp. 867-869
Authors:
TESTA A
GEBBIA V
BORSELLINO N
VALENZA R
CANNATA G
TIRRITO M
VERDERAME F
ARMATA MG
VALERIO MR
GEBBIA N
Citation: A. Testa et al., USEFULNESS OF ORAL MEDROXYPROGESTERONE ACETATE IN THE MANAGEMENT OF CANCER-RELATED CACHEXIA-ANOREXIA SYNDROME, Oncology Reports, 3(3), 1996, pp. 493-496
Authors:
GEBBIA V
MAIELLO E
TESTA A
CANNATA G
COLUCCI G
GEBBIA N
Citation: V. Gebbia et al., SINGLE-AGENT VINORELBINE IN THE TREATMENT OF UNRESECTABLE LUNG METASTASES FROM COLORECTAL-CANCER, Oncology Reports, 3(3), 1996, pp. 563-565
Authors:
MANTOVANI G
GEBBIA V
PROTO E
COSSU F
BIANCHI A
CURRELI L
GHIANI M
MASSA E
ASTARA G
LAMPIS B
DESSI D
SANTONA MC
Citation: G. Mantovani et al., NEOADJUVANT (PRIMARY) ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENTOF LOCALLY ADVANCED LARYNGEAL CARCINOMA - LARYNX PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(5), 1996, pp. 1035-1043
Authors:
MANTOVANI G
GEBBIA V
PROTO E
COSSU F
BIANCHI A
CURRELI L
GHIANI M
ASTARA G
LAMPIS B
DESSI D
SANTONA MC
MASSA E
Citation: G. Mantovani et al., NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED ORAL CAVITY AND OROPHARYNX CANCER - A TENTATIVE QUANTITATIVE-EVALUATION OF ORGAN PRESERVATION AND CLINICAL-RESPONSE, International journal of oncology, 9(3), 1996, pp. 571-578
Authors:
GEBBIA V
TESTA A
CANNATA G
GEBBIA N
Citation: V. Gebbia et al., SINGLE-AGENT PACLITAXEL IN ADVANCED SQUAMOUS-CELL HEAD AND NECK-CARCINOMA, European journal of cancer, 32A(5), 1996, pp. 901-902
Authors:
GEBBIA N
GEBBIA V
Citation: N. Gebbia et V. Gebbia, SINGLE-AGENT PACLITAXEL IN THE TREATMENT OF UNRESECTABLE AND OR METASTATIC PANCREATIC ADENOCARCINOMA/, European journal of cancer, 32A(10), 1996, pp. 1822-1823
Authors:
GEBBIA V
TESTA A
CANNATA G
GEBBIA N
Citation: V. Gebbia et al., TREATMENT OF CISPLATIN-RELATED NAUSEA AND VOMITING WITH A COMBINATIONOF ONDANSETRON AND METOCLOPRAMIDE - A PILOT-STUDY, Anti-cancer drugs, 7(7), 1996, pp. 734-737
Authors:
GEBBIA V
TESTA A
MAJELLO E
CANNATA G
TIRRITO ML
MASTRANDREA G
FEO M
BAJARDI G
COLUCCI G
GEBBIA N
Citation: V. Gebbia et al., SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND INTRAVENOUS 5-FLUOROURACIL PLUS HIGH-DOSE LEVOFOLINIC ACID AS SALVAGE TREATMENT FOR METASTATIC COLORECTAL-CARCINOMA, Anti-cancer drugs, 7(4), 1996, pp. 386-391
Authors:
GRIDELLI C
PERRONE F
PALMERI S
DAPRILE M
COGNETTI F
ROSSI A
GEBBIA V
PEPE R
VELTRI E
AIROMA G
RUSSO A
INCORONATO P
SCINTO AF
PALAZZOLO G
NATALI M
LEONARDI V
GALLO C
DEPLACIDO S
BIANCO AR
Citation: C. Gridelli et al., MITOMYCIN-C PLUS VINDESINE PLUS ETOPOSIDE (MEV) VERSUS MITOMYCIN-C PLUS VINDESINE PLUS CISPLATIN (MVP) IN STAGE-IV NON-SMALL-CELL LUNG-CANCER - A PHASE-III MULTICENTER RANDOMIZED TRIAL, Annals of oncology, 7(8), 1996, pp. 821-826
Authors:
GRIDELLI C
DAPRILE M
PALMERI S
CURCIO C
ROSSI A
GEBBIA V
VELTRI E
PEPE R
PISTILLUCCI G
BIANCO AR
Citation: C. Gridelli et al., PHASE-I STUDY OF CHEMOTHERAPY WITH CARBOPLATIN, EPIRUBICIN, AND ESCALATING DOSE OF VP-16 WITH G-CSF SUPPORT IN EXTENSIVE SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 19(6), 1996, pp. 589-591
Authors:
GEBBIA V
GALETTA D
MAJELLO E
VALENZA R
COLUCCI G
GEBBIA N
Citation: V. Gebbia et al., TREATMENT OF STAGE III-IV NON-SMALL-CELL LUNG-CARCINOMA WITH VINORELBINE IN COMBINATION WITH IFOSFAMIDE PLUS MESNA - A STUDY BY THE SOUTHERN ITALY ONCOLOGY GROUP (GOIM), American journal of clinical oncology, 19(3), 1996, pp. 278-280
Authors:
MAIELLO E
GIOTTA F
GEBBIA V
TESTA A
GALETTA D
RICCARDI F
GEBBIA N
COLUCCI G
Citation: E. Maiello et al., MITOMYCIN-C AND LONIDAMINE AS 2ND-LINE TREATMENT OF ADVANCED COLORECTAL-CANCER PATIENTS, Anticancer research, 16(5B), 1996, pp. 3177-3179
Authors:
COLUCCI G
MAIELLO E
GEBBIA V
CIFARELLI RA
BIGLIETTO M
PEDICINI A
DURINI E
GIULIANI F
GEBBIA N
Citation: G. Colucci et al., EPIDOXORUBICIN AND DOUBLE BIOCHEMICAL 5-FLUOROURACIL MODULATION WITH FOLINIC ACID AND HUMAN LYMPHOBLASTOID INTERFERON IN ADVANCED GASTRIC-CARCINOMA - A MULTICENTRIC PHASE-II STUDY OF THE SOUTHERN ITALY ONCOLOGY GROUP (GOIM), Oncology, 53(4), 1996, pp. 269-274